ABSTRACT
Risk assessment is an important part of the clinical evaluation of patients with acute coronary syndromes (ACS). It can determine the prognosis and the response to medical and interventional therapies, guide clinical decisions as to which therapeutic approach is most appropriate, indicate the likely duration of the hospital stay, and provide information for patients and relatives.
